14-day Premium Trial Subscription Try For FreeTry Free
$1.37
+0 (+0%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.31 $2.47 Wednesday, 24th Apr 2024 AKBA stock ended at $1.37. During the day the stock fluctuated 3.70% from a day low at $1.35 to a day high of $1.40.
90 days $1.31 $2.47
52 weeks $0.682 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jan 06, 2022 $2.26 $2.32 $2.20 $2.26 2 746 300
Jan 05, 2022 $2.36 $2.43 $2.24 $2.24 2 809 900
Jan 04, 2022 $2.47 $2.49 $2.31 $2.36 2 324 174
Jan 03, 2022 $2.28 $2.48 $2.28 $2.45 2 476 870
Dec 31, 2021 $2.29 $2.35 $2.24 $2.26 3 532 806
Dec 30, 2021 $2.31 $2.40 $2.26 $2.29 2 181 736
Dec 29, 2021 $2.29 $2.33 $2.22 $2.29 2 286 894
Dec 28, 2021 $2.42 $2.47 $2.20 $2.28 6 216 505
Dec 27, 2021 $2.50 $2.51 $2.39 $2.40 2 479 978
Dec 23, 2021 $2.51 $2.57 $2.47 $2.53 1 629 985
Dec 22, 2021 $2.50 $2.53 $2.43 $2.48 2 088 721
Dec 21, 2021 $2.48 $2.54 $2.44 $2.49 3 046 283
Dec 20, 2021 $2.39 $2.52 $2.35 $2.48 2 794 192
Dec 17, 2021 $2.36 $2.57 $2.34 $2.45 16 356 786
Dec 16, 2021 $2.49 $2.49 $2.33 $2.37 3 593 853
Dec 15, 2021 $2.42 $2.45 $2.22 $2.45 5 898 920
Dec 14, 2021 $2.50 $2.53 $2.36 $2.38 5 024 426
Dec 13, 2021 $2.49 $2.58 $2.43 $2.55 3 521 053
Dec 10, 2021 $2.59 $2.63 $2.48 $2.50 2 447 439
Dec 09, 2021 $2.66 $2.72 $2.55 $2.55 2 327 414
Dec 08, 2021 $2.72 $2.73 $2.63 $2.70 2 132 309
Dec 07, 2021 $2.61 $2.75 $2.61 $2.71 3 264 355
Dec 06, 2021 $2.52 $2.59 $2.43 $2.54 2 660 714
Dec 03, 2021 $2.70 $2.70 $2.51 $2.52 3 484 573
Dec 02, 2021 $2.56 $2.69 $2.52 $2.67 3 256 349
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT